Working Towards an Effective Treatment for COVID-19 - The ACTIV-2 Trial by Kara Chew, MD, MS

Working Towards an Effective Treatment for COVID-19 - The ACTIV-2 Trial by Kara Chew, MD, MS

UCLA Health via YouTube Direct link

Current antibody in the trial

22 of 23

22 of 23

Current antibody in the trial

Class Central Classrooms beta

YouTube videos curated by Class Central.

Classroom Contents

Working Towards an Effective Treatment for COVID-19 - The ACTIV-2 Trial by Kara Chew, MD, MS

Automatically move to the next video in the Classroom when playback concludes

  1. 1 Introduction
  2. 2 COVID19 Impact
  3. 3 COVID19 Cases Worldwide
  4. 4 COVID19 Cases in LA
  5. 5 Deaths by Age
  6. 6 Deaths by Race
  7. 7 Deaths by ethnicity
  8. 8 Course of COVID
  9. 9 Interventions
  10. 10 Symptoms
  11. 11 Treatment
  12. 12 Rise Above COVID
  13. 13 What is ACTIV
  14. 14 ACTIV2 Leadership
  15. 15 Eligibility Criteria
  16. 16 Risk Factors
  17. 17 How will we tell if the drugs work
  18. 18 How many participants do we need
  19. 19 What are the agents in the trial
  20. 20 What are monoclonal antibodies
  21. 21 How do monoclonal antibodies work
  22. 22 Current antibody in the trial
  23. 23 Spread the Word

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.